Resultados de la búsqueda 261-270 of 14055 for Metabolic acidosis

  1. Tumores y adenomas pituitarios

    The Journal of Clinical Endocrinology & Metabolism. 2016; doi:10.1210/jc.2016-2118. Tritos NA, et al. Diagnosis and management of pituitary adenomas: A ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...

  3. Oncología (médica) - Ensayos clínicos

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...

  6. Tumores y adenomas pituitarios

    The Journal of Clinical Endocrinology & Metabolism. 2016; doi:10.1210/jc.2016-2118. Tritos NA, et al. Diagnosis and management of pituitary adenomas: A ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    A Study To Evaluate Regulation Of The Metabolism Of T-Cells By The Tumor Microenvironment In Ovarian Cancer Metastasis. Scottsdale/Phoenix, Ariz. The purpose ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The hostile TME can also drive CAR T-cells to functional exhaustion and metabolic dysfunction, thus blunting the therapeutic efficacy of CAR T-cells.[3] ...